Clinical performance of two new, fully integrated molecular platforms used for HIV-1, HBV and HCV viral load analysis, the NeuMoDx 288 and the Alinity m.

K Mourik,S A Boers,A L van Rijn, J C P Thijssen,E Wessels,E C J Claas

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology（2023）

Cited 0|Views19

No score

Abstract

The Alinity m and NeuMoDx HCV assay have a comparable performance. Quantification differences in the HIV-1 assay were mostly apparent in the lower VLs and under-quantification of the NeuMoDx HBV assay was observed.

Translated text

Key words

Fully automated molecular platform,HBV,HCV,HIV,Viral load testing

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined